With more than 40 events throughout the year, LSPA has something for everyone. Whether you are looking to network with new business connections, get involved in our advocacy activity, or celebrate the achievements of the thriving Pennsylvania life sciences community, there is an LSPA event to meet your needs. Below are upcoming events, as well as recaps for our most recent programs.
Organizations within the life sciences discuss their culture, hiring practices, and managing the changing landscape of the workplace.
Life Sciences PA’s day at the ballpark! Enjoy a private catered stadium rooftop while networking with colleagues and taking in a Phillies game.
Life Sciences PA’s day at the ballpark! Enjoy a private catered stadium rooftop while networking with colleagues and taking in a Pirates game.
The conference will focus on various topics within the medical device, diagnostics, and digital health industries. Conference features include partnering, keynote sessions and networking throughout the days.
LSPA partners with experts at KPMG to provide members with a timely and relevant series for financial planning and operations.
This event is designed to provide entrepreneurs a combination of firsthand experience, best approaches, tips and to-dos from seasoned industry executives to perfect their company pitch.
This conference will include the most popular conference features, including keynotes, one-on-one partnering, and networking and but will focus on various topics within the biotechnology and pharmaceutical industries.
The Patient Summit provides the opportunity to start a conversation between Patient Advocacy Groups (PAGs), legislators, and LSPA member companies.
Join familiar faces and take the opportunity to make new connections as we reconnect for a casual lunch with Western PA’s life sciences community.
Our Holiday Mixer Hosted by LSPA Board of Directors is a time to celebrate the year’s achievements and bring our members together one last time before the end of the year.
These education sessions for members, legislators, and patient advocacy groups will highlight how public policy affects rare disease patients and their access to treatment and therapies.